Alemtuzumab for refractory celiac disease

N Engl J Med. 2006 Sep 28;355(13):1396-7; author reply 1397. doi: 10.1056/NEJMc061784.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Aged
  • Alemtuzumab
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Celiac Disease / drug therapy*
  • Celiac Disease / immunology
  • Female
  • Humans
  • T-Lymphocytes* / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Alemtuzumab